Lung cancer kills more individuals than any other malignancy. In the United States alone, it
is estimated that 142,670 patients with die of this disease during 2019 (1). In 1995, Hellman …

Резюме Рак легкого является самой распространенной формой злокачественных
опухолей в мире. Большинство больных с вновь установленным диагнозом имеют …

Locally advanced (LA) non-small-cell lung cancer (NSCLC) is the major target group for
clinical investigation in thoracic oncology because of the number of patients falling into this …

Résumé Le pronostic des cancers bronchiques non à petites cellules (CBNPC) localement
avancés non résécables reste mauvais, malgré les progrès thérapeutiques accomplis ces …

In the past 2 decades, many trials of combined-modality treatment in patients with locally
advanced (stage III) non–small cell lung cancer (NSCLC) have been published. Results of …

Background: Lung cancer is the leading cause of cancer deaths, having caused an
estimated 1.6 million deaths worldwide in 2012.[1] Materials and Methods: Although the …

Le document est divisé en cinq parties. D'abord, des algorithmes décisionnels sont
présentés. Ensuite, les principales recommandations sont rapportées par thématique. Le …

Surgery in elderly patients affected by NSCLC is safe and feasible when careful
preoperative respiratory and cardiac studies have been carried on. The surgical treatment is …

Targetnye preparatyi luchevaya terapiya v lecheniimestnorasprostranennogo raka legkogo -
Ragulin - Journal of Modern Oncology English Русский 简体中文 Eco-vector Journal of Modern …

Lung cancer is the leading cause of cancer-related mortality worldwide, accounting for over
one million deaths annually [1]. An estimated 222,520 men and women in the USA will be …